The gut-liver axis in hepatobiliary diseases

Masataka Ichikawa,Haruka Okada,Nobuhiro Nakamoto,Nobuhito Taniki,Po-Sung Chu,Takanori Kanai

DOI: https://doi.org/10.1186/s41232-023-00315-0

2024-01-08

Inflammation and Regeneration

Abstract:Abstract Recent advances in the analysis of intestinal bacteria have led to reports of variations in intestinal bacterial levels among hepatobiliary diseases. The mechanisms behind the changes in intestinal bacteria in various hepatobiliary diseases include the abnormal composition of intestinal bacteria, weakening of the intestinal barrier, and bacterial translocation outside the intestinal tract, along with their metabolites, but many aspects remain unresolved. Further research employing clinical studies and animal models is expected to clarify the direct relationship between intestinal bacteria and hepatobiliary diseases and to validate the utility of intestinal bacteria as a diagnostic biomarker and potential therapeutic target. This review summarizes the involvement of the microbiota in the pathogenesis of hepatobiliary diseases via the gut-liver axis.

immunology,medicine, research & experimental

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of the gut microbiota in the pathogenesis of hepatobiliary diseases and the specific mechanisms through the gut - liver axis. Specifically, the paper focuses on the following aspects:

1. **Relationship between changes in gut bacteria and hepatobiliary diseases**: Recent advances in gut bacteria analysis have revealed changes in gut bacteria levels in different hepatobiliary diseases. The mechanisms behind these changes include abnormalities in gut bacteria composition, weakened gut barrier function, and translocation of bacteria and their metabolites outside the gut, etc., but many aspects remain unclear.

2. **Potential of gut bacteria as diagnostic markers and therapeutic targets**: Further research, through clinical studies and animal models, aims to clarify the direct relationship between gut bacteria and hepatobiliary diseases and verify the effectiveness of gut bacteria as diagnostic markers and potential therapeutic targets.

3. **Function and structure of the gut barrier**: The paper describes in detail the four - layer structure of the gut barrier, including the mucus layer, epithelial layer, lamina propria, and intestinal vascular barrier, as well as their roles in preventing bacterial invasion and maintaining immune balance.

4. **Interaction between immune cells and gut bacteria**: It discusses the close connection between the innate immune system and commensal bacteria, especially the role of pattern - recognition receptors (PRRs) such as Toll - like receptors (TLRs) in responding to microbial signals and how these signals affect the occurrence of liver inflammation and fibrosis.

5. **Bile acids and the entero - hepatic cycle**: It expounds on the roles of bile acids in lipid digestion and absorption, regulating liver metabolism, affecting gut microbiota composition and gut permeability, etc., as well as the mechanisms for regulating bile acid balance through nuclear receptors such as FXR and G - protein - coupled receptors such as TGR5.

6. **Influence of metabolites**: It introduces the roles of metabolites such as short - chain fatty acids (SCFAs) and amino acids in energy metabolism, immunomodulation, and improving gut barrier function, as well as their potential applications in the treatment of liver diseases.

In summary, this review article aims to comprehensively summarize the latest research progress on the participation of the gut microbiota in the pathogenesis of hepatobiliary diseases through the gut - liver axis and provide guidance for future research directions.